Pfizer Wants Dozens Tossed From Bextra MDL
Pfizer Inc. has asked a court to dismiss the claims of dozens of plaintiffs in the multidistrict litigation over the arthritis drugs Celebrex and Bextra, alleging the plaintiffs have repeatedly failed...To view the full article, register now.
Already a subscriber? Click here to view full article